Hema
2 known investors
hema.to provides AI-powered cytometry analysis software that automates manual gating and reporting workflows for laboratory diagnostics. The platform enables remote cloud-based collaboration, reduces analysis time, and improves reproducibility for clinical and research labs.
Investors · 2
Frequently asked questions
- What does Hema do?
- hema.to provides AI-powered cytometry analysis software that automates manual gating and reporting workflows for laboratory diagnostics. The platform enables remote cloud-based collaboration, reduces analysis time, and improves reproducibility for clinical and research labs.
- Who are Hema's investors?
- Hema's investors include Heal Capital, Elaia.